These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8062225)
1. Two significant aspects of microcystin-LR: specific binding and liver specificity. Nishiwaki R; Ohta T; Sueoka E; Suganuma M; Harada K; Watanabe MF; Fujiki H Cancer Lett; 1994 Aug; 83(1-2):283-9. PubMed ID: 8062225 [TBL] [Abstract][Full Text] [Related]
2. 14C-labeled microcystin-LR administered to Atlantic salmon via intraperitoneal injection provides in vivo evidence for covalent binding of microcystin-LR in salmon livers. Williams DE; Craig M; Dawe SC; Kent ML; Andersen RJ; Holmes CF Toxicon; 1997 Jun; 35(6):985-9. PubMed ID: 9241792 [TBL] [Abstract][Full Text] [Related]
3. Association of microcystin-LR and its biotransformation product with a hepatic-cytosolic protein. Robinson NA; Matson CF; Pace JG J Biochem Toxicol; 1991; 6(3):171-80. PubMed ID: 1770501 [TBL] [Abstract][Full Text] [Related]
4. Identification of protein phosphatase 2A as the primary target for microcystin-LR in rat liver homogenates. Toivola DM; Eriksson JE; Brautigan DL FEBS Lett; 1994 May; 344(2-3):175-80. PubMed ID: 8187879 [TBL] [Abstract][Full Text] [Related]
5. A molecular basis for different interactions of marine toxins with protein phosphatase-1. Molecular models for bound motuporin, microcystins, okadaic acid, and calyculin A. Bagu JR; Sykes BD; Craig MM; Holmes CF J Biol Chem; 1997 Feb; 272(8):5087-97. PubMed ID: 9030574 [TBL] [Abstract][Full Text] [Related]
7. Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver. Ohta T; Sueoka E; Iida N; Komori A; Suganuma M; Nishiwaki R; Tatematsu M; Kim SJ; Carmichael WW; Fujiki H Cancer Res; 1994 Dec; 54(24):6402-6. PubMed ID: 7527297 [TBL] [Abstract][Full Text] [Related]
8. Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR. Nishiwaki-Matsushima R; Ohta T; Nishiwaki S; Suganuma M; Kohyama K; Ishikawa T; Carmichael WW; Fujiki H J Cancer Res Clin Oncol; 1992; 118(6):420-4. PubMed ID: 1618889 [TBL] [Abstract][Full Text] [Related]
9. Structure-function relationships of microcystins, liver tumor promoters, in interaction with protein phosphatase. Nishiwaki-Matsushima R; Nishiwaki S; Ohta T; Yoshizawa S; Suganuma M; Harada K; Watanabe MF; Fujiki H Jpn J Cancer Res; 1991 Sep; 82(9):993-6. PubMed ID: 1657848 [TBL] [Abstract][Full Text] [Related]
10. Evidence for a covalently bound form of microcystin-LR in salmon liver and Dungeness crab larvae. Williams DE; Craig M; McCready TL; Dawe SC; Kent ML; Holmes CF; Andersen RJ Chem Res Toxicol; 1997 Apr; 10(4):463-9. PubMed ID: 9114985 [TBL] [Abstract][Full Text] [Related]
11. Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin. Fischer WJ; Altheimer S; Cattori V; Meier PJ; Dietrich DR; Hagenbuch B Toxicol Appl Pharmacol; 2005 Mar; 203(3):257-63. PubMed ID: 15737679 [TBL] [Abstract][Full Text] [Related]
12. Hyperphosphorylation of cytokeratins 8 and 18 by microcystin-LR, a new liver tumor promoter, in primary cultured rat hepatocytes. Ohta T; Nishiwaki R; Yatsunami J; Komori A; Suganuma M; Fujiki H Carcinogenesis; 1992 Dec; 13(12):2443-7. PubMed ID: 1282096 [TBL] [Abstract][Full Text] [Related]
13. Isolation of Adda from microcystin-LR by microbial degradation. Harada K; Imanishi S; Kato H; Mizuno M; Ito E; Tsuji K Toxicon; 2004 Jul; 44(1):107-9. PubMed ID: 15225569 [TBL] [Abstract][Full Text] [Related]
14. Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A protein phosphatases. Honkanen RE; Zwiller J; Moore RE; Daily SL; Khatra BS; Dukelow M; Boynton AL J Biol Chem; 1990 Nov; 265(32):19401-4. PubMed ID: 2174036 [TBL] [Abstract][Full Text] [Related]
15. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases. Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, organotropism and hepatocellular uptake of two tritium-labeled epimers of dihydromicrocystin-LR, a cyanobacterial peptide toxin analog. Meriluoto JA; Nygård SE; Dahlem AM; Eriksson JE Toxicon; 1990; 28(12):1439-46. PubMed ID: 2128565 [TBL] [Abstract][Full Text] [Related]
17. Tumor promoters--microcystin-LR, nodularin and TNF-α and human cancer development. Fujiki H; Suganuma M Anticancer Agents Med Chem; 2011 Jan; 11(1):4-18. PubMed ID: 21269254 [TBL] [Abstract][Full Text] [Related]
18. The uptake of the cyanobacterial hepatotoxin microcystin by isolated rat hepatocytes. Runnegar MT; Gerdes RG; Falconer IR Toxicon; 1991; 29(1):43-51. PubMed ID: 1903001 [TBL] [Abstract][Full Text] [Related]
19. Enzymatic pathway for the bacterial degradation of the cyanobacterial cyclic peptide toxin microcystin LR. Bourne DG; Jones GJ; Blakeley RL; Jones A; Negri AP; Riddles P Appl Environ Microbiol; 1996 Nov; 62(11):4086-94. PubMed ID: 8899999 [TBL] [Abstract][Full Text] [Related]
20. Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants. MacKintosh C; Beattie KA; Klumpp S; Cohen P; Codd GA FEBS Lett; 1990 May; 264(2):187-92. PubMed ID: 2162782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]